CTRV Stock Soars 40% as FDA Issues Positive Response for CRV431
CTRV stock is one of the biggest biotech stocks after ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) gets a positive response from the FDA to its pre-IND meeting for developing CRV431 in NASH. Big Announcement New Jersey-based biopharmaceutical ... [Read]